To include your compound in the COVID-19 Resource Center, submit it here.

PSI-7977: Phase IIb expanded

Pharmasset expanded the U.S. Phase IIb ELECTRON trial evaluating 400 mg PSI-7977 daily to include 3 cohorts and an additional 30

Read the full 212 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE